Risk of thrombosis in patients homozygous for factor V Leiden.
Samama
M M
MM
Trossaërt
M
M
Horellou
M H
MH
Elalamy
I
I
Conard
J
J
Deschamps
A
A
D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D005165:Factor V / Q000235:genetics*; D005166:Factor V Deficiency / Q000150:complications* / Q000235:genetics; D005260:Female; D020022:Genetic Predisposition to Disease; D006720:Homozygote; D006801:Humans; D007103:Immobilization / Q000009:adverse effects; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000209:etiology; D011486:Protein C / Q000378:metabolism; D011655:Pulmonary Embolism / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D012306:Risk; D012307:Risk Factors; D013924:Thrombophlebitis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control
D000925:Anticoagulants; D003278:Contraceptives, Oral, Hormonal; D011486:Protein C; C095381:factor V Leiden; D005165:Factor V